 Founded in 1964
| The Dermatology Foundation Established in 1964, the Foundation is a 501(c)3 charitable organization dedicated to enabling advancements in patient care. The DF accomplishes this important work by providing research funding each year to promising early and mid-career investigators whose novel ideas have the potential to shape the future of the specialty. Thanks to its many physician members and industry constituents over more than five decades, the DF funding has had a tremendous long-term effect on the specialty. Foundation support has helped to:
With the continued support of dermatologists, specialty societies and corporate supporters, the DF can continue to further progress in all areas of the specialty, for the benefit of patients everywhere.  A Special Message from the DF President Dear Colleagues, Membership in the Dermatology Foundation is an easy and simple way for every dermatologist to support the most innovative research proposed by promising investigators in our specialty. Advancements in patient care begin with DF funding that is made possible by our combined contributions. This year, the need for our help is greater than ever. If you are a DF member, thank you for your ongoing support. If you have not yet renewed your membership or are new to the Foundation, please join me and many of our colleagues in furthering progress in our field and our future. To join, call the DF office at 847-328-2256 or visit the DF Contribution Center. My best wishes for a safe and healthy holiday season, Janet A. Fairley, MD The DF: Where Innovation Begins
The long-term results of the Dermatology Foundation's work are profound. For over 50 years, the DF has focused on furthering patient care by funding innovative research pursued by promising investigators. It has identified and launched a pool of innovators who have brought the specialty a greater understanding of dermatologic diseases—and new treatments—benefiting patients everywhere. A shining example of this has been the wonderful contributions DF-funded investigators have made to the current treatment of psoriasis. |
|
